|
LOC100132707 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.44009282066327E-15 |
| Normal-vs-Stage2 |
1.77501999999441E-05 |
| Normal-vs-Stage3 |
1.46893608388154E-12 |
| Normal-vs-Stage4 |
1.49540047011953E-10 |
| Stage1-vs-Stage2 |
2.386600E-01 |
| Stage1-vs-Stage3 |
4.746600E-01 |
| Stage1-vs-Stage4 |
3.263200E-01 |
| Stage2-vs-Stage3 |
1.385360E-01 |
| Stage2-vs-Stage4 |
1.105180E-01 |
| Stage3-vs-Stage4 |
6.900600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44089209850063E-16 |
| Normal-vs-AfricanAmerican |
1.843130E-04 |
| Normal-vs-Asian |
2.17359996668165E-09 |
| Caucasian-vs-AfricanAmerican |
4.461200E-01 |
| Caucasian-vs-Asian |
4.809200E-01 |
| AfricanAmerican-vs-Asian |
2.862800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63202784619898E-14 |
| Normal-vs-Female |
1.63125069008174E-12 |
| Male-vs-Female |
2.039600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.86295423532101E-12 |
| Normal-vs-Age(41-60Yrs) |
1.01341157687784E-12 |
| Normal-vs-Age(61-80Yrs) |
4.15399936670724E-11 |
| Normal-vs-Age(81-100Yrs) |
3.55779999999806E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.721200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.663600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.072970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.632400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.149050E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.365180E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.430000E-02 |
| Classical-VS-Follicular |
2.776400E-02 |
| Classical-VS-Other |
1.763000E-01 |
| Classical-VS-Normal |
6.00070004797004E-09 |
| Tall-VS-Follicular |
9.458000E-01 |
| Tall-VS-Other |
5.049600E-01 |
| Tall-VS-Normal |
4.65899985258034E-10 |
| Follicular-VS-Other |
5.883600E-01 |
| Follicular-VS-Normal |
1.55649937383373E-11 |
| Other-VS-Normal |
6.626200E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.09019476674166E-12 |
| Normal-vs-N1 |
3.01003666436372E-12 |
| N0-vs-N1 |
1.538440E-02 |
|
|
